Search research articles
Contact Us
Filters
Showing results (291-300 of 527) with videos related to
Page
of 53
Sort By:
The Kaohsiung Journal of Medical Sciences
|
February 16, 2024
Third vaccine boosters and anti-S-IgG levels: A comparison of homologous and heterologous responses and poor immunogenicity in hepatocellular carcinoma
Chih-Wen Wang, Chung-Feng Huang, Tyng-Yuan Jang, et al.
The Kaohsiung Journal of Medical Sciences
|
September 2, 2023
Unawareness of hepatitis B infection and lack of surveillance are associated with severity of hepatocellular carcinoma
Kuan-I Lee, Po-Cheng Liang, Po-Yau Hsu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
May 2, 2020
2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations
Ming-Lung Yu, Pei-Jer Chen, Chia-Yen Dai, et al.
Pharmacogenomics
|
August 5, 2006
Genetic predisposition of responsiveness to therapy for chronic hepatitis C
Yuchi Hwang, Ellson Y Chen, Z John Gu, et al.
Plos One
|
September 5, 2018
Significant predictors of overall survival in patients with hepatocellular carcinoma after surgical resection
Chih-Wen Lin, Yaw-Sen Chen, Chih-Che Lin, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
February 24, 2012
The outcomes of glucose abnormalities in pre-diabetic chronic hepatitis C patients receiving peginterferon plus ribavirin therapy
Jee-Fu Huang, Ming-Lung Yu, Chung-Feng Huang, et al.
Hepatology International
|
October 25, 2011
Thyroid autoantibodies and dysfunction do not impact the treatment efficacy of peginterferon and ribavirin combination therapy in chronic hepatitis C
Jee-Fu Huang, Chao-Kuan Huang, Ming-Lung Yu, et al.
Journal of Hepatology
|
January 22, 2009
Serum retinol-binding protein 4 is inversely correlated with disease severity of chronic hepatitis C
Jee-Fu Huang, Chia-Yen Dai, Ming-Lung Yu, et al.
Annals of Hepatology
|
June 18, 2026
Asia-Pacific perspectives on the steatotic liver disease (SLD) reclassification: balancing terminology, diagnostic criteria, and implementation
Kuo Chao Yew, Quan Rui Tan, Bernett Lee, et al.
Clinical and Molecular Hepatology
|
August 29, 2020
Use of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus infection and severe renal impairment
Desmond Y H Yap, Kevin S H Liu, Yu-Chun Hsu, et al.
Page
of 53
Search research articles
Search
Showing results (291-300 of 527) with videos related to
Sort By:
Page
of 53
The Kaohsiung Journal of Medical Sciences
|
February 16, 2024
Third vaccine boosters and anti-S-IgG levels: A comparison of homologous and heterologous responses and poor immunogenicity in hepatocellular carcinoma
Chih-Wen Wang, Chung-Feng Huang, Tyng-Yuan Jang, et al.
The Kaohsiung Journal of Medical Sciences
|
September 2, 2023
Unawareness of hepatitis B infection and lack of surveillance are associated with severity of hepatocellular carcinoma
Kuan-I Lee, Po-Cheng Liang, Po-Yau Hsu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
May 2, 2020
2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations
Ming-Lung Yu, Pei-Jer Chen, Chia-Yen Dai, et al.
Pharmacogenomics
|
August 5, 2006
Genetic predisposition of responsiveness to therapy for chronic hepatitis C
Yuchi Hwang, Ellson Y Chen, Z John Gu, et al.
Plos One
|
September 5, 2018
Significant predictors of overall survival in patients with hepatocellular carcinoma after surgical resection
Chih-Wen Lin, Yaw-Sen Chen, Chih-Che Lin, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
February 24, 2012
The outcomes of glucose abnormalities in pre-diabetic chronic hepatitis C patients receiving peginterferon plus ribavirin therapy
Jee-Fu Huang, Ming-Lung Yu, Chung-Feng Huang, et al.
Hepatology International
|
October 25, 2011
Thyroid autoantibodies and dysfunction do not impact the treatment efficacy of peginterferon and ribavirin combination therapy in chronic hepatitis C
Jee-Fu Huang, Chao-Kuan Huang, Ming-Lung Yu, et al.
Journal of Hepatology
|
January 22, 2009
Serum retinol-binding protein 4 is inversely correlated with disease severity of chronic hepatitis C
Jee-Fu Huang, Chia-Yen Dai, Ming-Lung Yu, et al.
Annals of Hepatology
|
June 18, 2026
Asia-Pacific perspectives on the steatotic liver disease (SLD) reclassification: balancing terminology, diagnostic criteria, and implementation
Kuo Chao Yew, Quan Rui Tan, Bernett Lee, et al.
Clinical and Molecular Hepatology
|
August 29, 2020
Use of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus infection and severe renal impairment
Desmond Y H Yap, Kevin S H Liu, Yu-Chun Hsu, et al.
Page
of 53